InvestSMART

Patrys Limited (ASX:PAB)

ALERT: Price-sensitive ASX Announcement for PAB
Current share price for PAB : $0.025 -0.005 (-16.67%)+
Announcement
Release
6 Oct 2026 10:26AM
Price at Release
$0.030
Full Release
download
Summary
Patrys Limited announced that its Chief Executive Officer, Dr Samantha South, will present at the MST Biotech & Healthcare Webinar – New Discoveries on Tuesday, 13 October 2026 at 2:00pm AWST / 4:00pm AEDT. The webinar will feature four ASX-listed biotech and healthcare companies focused on new discoveries and the future of healthcare, and Patrys invited investors and shareholders to register via the provided link. The announcement was authorised by the Board of Directors, and the release also notes that Patrys is a clinical-stage company developing an injectable therapy for delirium and a differentiated deoxymab platform targeting immune-mediated inflammatory diseases.
Key Points
  • Patrys Limited announced its participation in the MST Biotech & Healthcare Webinar – New Discoveries.
  • Dr Samantha South, Chief Executive Officer, is scheduled to present on Tuesday, 13 October 2026.
  • The webinar time is 2:00pm AWST / 4:00pm AEDT.
  • The event will feature four ASX-listed biotech and healthcare companies.
  • Investors and shareholders were invited to register for the webinar through the provided registration link.
  • The announcement was authorised for release by the Board of Directors of Patrys Limited.
  • Patrys describes itself as a clinical-stage company developing an injectable therapy for delirium and a deoxymab platform for immune-mediated inflammatory diseases.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.